Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NPAA Takes Action Against 93 Drug Brands (India)

This article was originally published in PharmAsia News

Executive Summary

India's National Pharmaceutical Pricing Authority (NPAA) has instituted a serious crackdown on drug companies who promised to cut prices but have not done so. Previously, the pharmaceutical manufacturers made an agreement with the agency to reduce the price of 886 brands. Now, the NPAA has instituted fixed pricing for 37 brands. It is now also obligated the producers of 56 other brands to reimburse the government for the amount they overcharged. According to NPAA representatives, this is only the beginning. A survey of 12 of the countries largest cities found approximately half of the 574 samples were also guilty of overcharging. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065777

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel